Crossmark

Analysis of the conditions for applying BRCA genetic testing to women with breast cancer using the Japanese HBOC consortium and the Japanese organization of hereditary breast and ovarian cancer (JOHBOC) registry project database

Crossref DOI link: https://doi.org/10.1007/s12282-025-01704-8

Published Online: 2025-05-05

Published Print: 2025-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Takahashi, Masato https://orcid.org/0000-0002-6641-9598
Minoura, Yuko https://orcid.org/0000-0003-1926-2927
Den, Hiroki https://orcid.org/0000-0002-2530-3804
Nomizu, Tadashi

Ishida, Takanori https://orcid.org/0000-0003-4565-4721
Kumamaru, Hiraku

Arai, Masami https://orcid.org/0000-0001-7544-4536
Nakamura, Seigo https://orcid.org/0000-0001-6597-9107
Funding

Funding for this research was provided by:

JOHBOC
License Information

Text and Data Mining valid from 2025-05-05

Version of Record valid from 2025-05-05
More Information

Article History

Received: 18 December 2024

Accepted: 14 April 2025

First Online: 5 May 2025

Declarations

:

: Masato Takahashi received lecture fees or honoraria from Astra Zeneca, Daiichi Sankyo, Eisai, Eli Lilly, MSD and Pfizer. Tadanori Ishida received lecture fees or honoraria from Astra Zeneca. Other authors declare that there is no conflict of interest..

Document is current

Any future updates will be listed below